Compare Visa Inc (V) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Visa Inc vs Zimmer Biomet Holdings Inc — how do they compare? Visa Inc trades at $369.82 (market cap $691.22B), while Zimmer Biomet Holdings Inc trades at $94.73 (market cap $18.05B). The key difference: Visa Inc is far larger — about 38.3× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.01%). Which is the better fit depends on your goals.
| V | ZBH | |
|---|---|---|
Market Cap | $691.22B | $18.05B |
Volume | 10,431,336 | — |
Sector | Financials | Health |
52-Week High | $384.14 | $104.26 |
52-Week Low | $295.52 | $79.58 |
Enterprise Value | $701.80B | $25.11B |
Dividend Yield | 0.73% | 1.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Visa (V) trades at $368.64, down 1.71% on the day, but maintains strong fundamentals with a 50.78% net income margin and consistent earnings beats. The stock is supported by a bullish technical signal, with key support at $366 and resistance at $372. Recent developments include the launch of Intelligent Commerce Connect to facilitate AI-driven commerce, positioning the company for future growth amid digital payment expansion.
The outlook for Visa remains positive, driven by robust profitability, strategic AI initiatives, and a consensus price target of $430.93 implying 17% upside. Risks include competitive pressures from fintech and stablecoins, as well as regulatory scrutiny. Wall Street sentiment is overwhelmingly bullish with 85% of analysts rating it a Buy, supported by institutional accumulation.
ZBH trades at $94.22, down 3.93% on the day, with a bearish technical signal but oversold RSI readings. Recent earnings beats and raised 2026 guidance support fundamentals, with revenue growth and strong gross margins. Leadership promotions aim to accelerate commercial transformation, while cash flow trends show operational strength.
The stock offers upside to the $104.88 consensus target, but faces headwinds from debt levels and competitive pressures. Near-term support at $92 is critical; a hold rating aligns with mixed analyst views. Earnings execution and procedure demand growth are key catalysts for valuation expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
